TSCAN THERAPEUTICS INC
TCRX·89854M101·US·Common Stock·Healthcare - Biotechnology-13D/G
TCRX (TSCAN THERAPEUTICS INC) is held by 44 institutional investors as of Q1 2026. Largest holders: BAKER BROS. ADVISORS LP ($2.8M), VANGUARD CAPITAL MANAGEMENT LLC ($2.2M), BlackRock, Inc. ($1.9M). Net institutional sentiment: Mixed.
44
Holders
Avg rating(12 Elite)
$16.2M
Total Value
47% (49)
Fund Consensus
20 buying - 23 selling
Who's Trading
ActivistBLBVF PARTNERS L P/IL10.0%May 15, 2026
InsiderLLLynx1 Capital Management LPBuy $6KDec 23, 2025
InsiderLLLynx1 Capital Management LPBuy $68KDec 22, 2025
InsiderLLLynx1 Capital Management LPBuy $72KDec 19, 2025
ActivistLYLynx1 Capital Management LP15.0%Aug 14, 2025
ActivistADAdage Capital Management, L.P.2.5%Aug 12, 2025
InsiderLLLynx1 Capital Management LPBuy $1.4MMay 20, 2025
InsiderLLLynx1 Capital Management LPBuy $1.7MMay 19, 2025
ActivistECEcoR1 Capital, LLC1.3%May 15, 2025
13F: Insider & Congress:
Showing 1-20 of 49
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer